Key Developments

On January 5, 2024, Biocare Medical, a leader in fully open automated instrumentation, announced a collaboration with Molecular Instruments (MI), the inventor of HCR imaging technology. This partnership combines Biocare Medical's expertise in automated bioimaging systems with MI's sophisticated HCR products, establishing a new standard for automated in situ hybridization (ISH) and immunohistochemistry (IHC).
In November 2023, Biocare Medical announced its latest product, the Antigen Retrieval Chamber (ARC). ARC is designed for Heat-Induced Epitope Retrieval (HIER) with in vitro diagnostic (IVD) labeling, ensuring precision and consistency. Recognizing the importance of precise heat, pressure, and buffer solutions, ARC is critical for reproducible immunohistochemistry (IHC) and in situ hybridization (ISH) labeling.
In July 2023, ImmunoChemistry Technologies, a privately-held biotechnology company, announced that the company now offers Immunohistochemistry (IHC) reagents. ImmunoChemistry Technologies offers a wide range of IHC products, including antigen retrievers, blocking reagents, buffers, counter stains, chromogens, and mounting media.
In March 2021, Roche, a multinational healthcare company, announced the launch of the DISCOVERY Green HRP kit, the latest addition to its extensive array of modular-based detection kits for identifying and profiling biomarkers and cell types in tissue-based research. The DISCOVERY Green HRP (horseradish peroxidase) kit can be used in conjunction with other detection kits to increase the multiplexing capabilities of immunohistochemistry (IHC) and in situ hybridization (ISH).

Immunohistochemistry Market Report Snapshots